Danimer Scientific Appoints Food and Beverage Industry Expert Deborah McRonald as Chief Corporate Development Officer

Rhea-AI Summary

Danimer Scientific (NYSE: DNMR) has announced the appointment of Deborah McRonald as Chief Corporate Development Officer. McRonald brings extensive experience from her previous roles at Nestlé and Wyeth Nutrition, where she led business development and technology licensing initiatives.

Her primary focus will be on fostering external collaborations and joint ventures aimed at driving revenue growth and reducing plastic waste globally. The company's growth strategy emphasizes partnerships that enhance market applications, aligning with Danimer’s mission of sustainability.

Positive

• Appointment of Deborah McRonald as Chief Corporate Development Officer is expected to enhance growth efforts.
• McRonald's background in business development at Nestlé could yield strategic collaborations, potentially increasing revenue.

Negative

• None.

McRonald to lead development of industry collaborations and joint ventures designed to grow global revenue, manufacturing and distribution capabilities

BAINBRIDGE, Ga.--(BUSINESS WIRE)-- Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”), a leading next generation bioplastics company focused on the development and production of biodegradable materials, today announced that Deborah McRonald has joined the Company to serve in the newly created position of Chief Corporate Development Officer.

With many years of experience leading business development and technology licensing initiatives across the pharmaceutical, consumer goods, maternal and infant nutrition, and food and beverage industries, McRonald will focus on developing external collaborations that drive revenue and fulfill the Company’s mission of reducing plastic waste across the globe. These collaborations are expected to include potential licensing or joint-venture agreements with various partners to further increase market applications for Danimer’s technology and materials, as well as to enhance the Company’s returns on invested capital.

“As our rapid growth plans progress, we will continue developing a strong portfolio of customer and industry collaborations, and Deborah is the ideal candidate to execute this strategy,” said Stephen E. Croskrey, Chief Executive Officer at Danimer Scientific. “Her years of experience at Nestlé establishing many types of partnerships, including new forms of consumer packaging, will be invaluable in guiding our own strategic collaborations. We are excited to welcome Deborah to the Danimer family.”

McRonald joins Danimer after almost eight years of overseeing Technology Licensing within Open Innovation & Venturing at Nestlé’s international headquarters in Vevey, Switzerland. Previous to Nestlé, she led Business Development at Wyeth Nutrition, a company focused on maternal and infant nutrition. She holds a Master of International Affairs with a concentration in International Finance and Business from Columbia University and a Bachelor of Arts from Assumption College in Politics and Philosophy.

“Since my first encounter with Danimer, I have been impressed by the team’s passionate and innovative approach to reducing the environmental impacts of plastic waste,” said McRonald. “It is exciting to join Danimer at this critical juncture for the Company’s growth. I look forward to working with the team to drive strategic collaborations that support Danimer’s mission and deliver value to shareholders.”

For more information on Danimer Scientific, visit www.DanimerScientific.com.

About Danimer Scientific

Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 390 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations. For more information, visit www.DanimerScientific.com.

Forward‐Looking Statements

Please note that in this press release we may use words such as “appears,” “anticipates,” “believes,” “plans,” “expects,” “intends,” “future,” and similar expressions which constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are made based on our expectations and beliefs concerning future events impacting the Company and therefore involve a number of risks and uncertainties. We caution that forward-looking statements are not guarantees and that actual results could differ materially from those expressed or implied in the forward-looking statements. Potential risks and uncertainties that could cause the actual results of operations or financial condition of the Company to differ materially from those expressed or implied by forward-looking statements in this release include, but are not limited to, the overall level of consumer demand on our products; general economic conditions and other factors affecting consumer confidence, preferences, and behavior; disruption and volatility in the global currency, capital, and credit markets; the financial strength of the Company's customers; the Company's ability to implement its business strategy, including, but not limited to, its ability to expand its production facilities and plants to meet customer demand for its products and the timing thereof; risks relating to the uncertainty of the projected financial information with respect to the Company; the ability of the Company to execute and integrate acquisitions; changes in governmental regulation, legislation or public opinion relating to our products; the Company’s exposure to product liability or product warranty claims and other loss contingencies; disruptions and other impacts to the Company’s business, as a result of the COVID-19 global pandemic and government actions and restrictive measures implemented in response; stability of the Company’s manufacturing facilities and suppliers, as well as consumer demand for our products, in light of disease epidemics and health-related concerns such as the COVID-19 global pandemic; the impact that global climate change trends may have on the Company and its suppliers and customers; the Company's ability to protect patents, trademarks and other intellectual property rights; any breaches of, or interruptions in, our information systems; the ability of our information technology systems or information security systems to operate effectively, including as a result of security breaches, viruses, hackers, malware, natural disasters, vendor business interruptions or other causes; our ability to properly maintain, protect, repair or upgrade our information technology systems or information security systems, or problems with our transitioning to upgraded or replacement systems; the impact of adverse publicity about the Company and/or its brands, including without limitation, through social media or in connection with brand damaging events and/or public perception; fluctuations in the price, availability and quality of raw materials and contracted products as well as foreign currency fluctuations; our ability to utilize potential net operating loss carryforwards; and changes in tax laws and liabilities, tariffs, legal, regulatory, political and economic risks. More information on potential factors that could affect the Company's financial results is included from time to time in the Company's public reports filed with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210913005092/en/

For Danimer:

Investors

ir@danimer.com

Phone: 229-220-1103



Media

Anthony Popiel

apopiel@daltonagency.com

Phone: 404-876-1309

Source: Danimer Scientific

FAQ

Who is Deborah McRonald?

Deborah McRonald is the new Chief Corporate Development Officer at Danimer Scientific, bringing extensive experience in business development from Nestlé and Wyeth Nutrition.

What is Deborah McRonald's role at Danimer Scientific?

She will focus on developing industry collaborations and joint ventures to drive revenue growth and advance Danimer's sustainability mission.

How will McRonald's appointment impact Danimer Scientific?

Her expertise is expected to strengthen Danimer's collaboration strategy and enhance market applications for its biodegradable materials.

What is the stock symbol for Danimer Scientific?

The stock symbol for Danimer Scientific is DNMR.